Below you can find the latest news releases from Desentum.

image description

Desentum raises EUR 2.3 million to test allergy vaccine

Desentum is progressing towards clinical stage with its first immunotherapeutic product targeting birch pollen allergy. It has raised approx. EUR 2.3 million in a crowd funding campaign arranged by a Finnish investment service company Kansalaisrahoitus. The funds raised in this round will be used...

Read more »